mutant p53 and oncogenic kras drive metastasis in pancreatic cancer
Published 3 years ago • 1K plays • Length 5:17Download video MP4
Download video MP3
Similar videos
-
0:51
personalized treatment approaches for patients with kras-mutant pancreatic cancer
-
0:41
improving outcomes in kras-mutant pancreatic cancer
-
1:10
future targets for pancreatic cancer treatment
-
2:42
assessing the heterogeneity of kras-mutant pancreatic adenocarcinomas
-
0:41
kras driven cancers (kras episode 2)
-
45:20
voice of pancreatic cancer podcast - targeting the kras mutation for more effective cancer treatment
-
1:45
the future of precision oncology in pancreatic cancer
-
3:53
the role of p53 in cancer
-
1:27
advances in the development of kras inhibitors
-
8:15
this research could change cancer treatment forever
-
1:17
codebreak100: assessing sotorasib in patients with kras p.g12c-mutant pancreatic cancer
-
1:58
tcr gene therapy in pancreatic cancer | nejm
-
0:41
p53 in colon cancer
-
1:19
restoration of wild-type tp53 in pancreatic cancer | aging-us
-
3:47
mutations of the p53 protein involved in cancer
-
1:07
the case for separating g12d mutations in studying kras-mutant pdac
-
4:04
recent advances in the management of pancreatic cancer
-
1:01:44
overcoming the undruggable nature of the most common human oncogene k-ras
-
4:15
prion like aggregation on mutant p53 in cancer